AZTA Azenta, Inc.
Price Chart
Executive Summary
Azenta reported Q2 FY2026 revenue of $145M (+1% reported, -3% organic), non-GAAP EPS of ($0.04) vs $0.01 a year ago, and a $149M goodwill impairment. FY2026 guidance was sharply cut: organic revenue now expected -2% to +1% (prior 3-5% growth) and Adjusted EBITDA margin expected -125bps to flat (prior +300bps expansion). Long-range plan extended to 2029, and B Medical Systems sale remains uncertain. The filing signals worsening demand and execution issues.
Key Financial Metrics
Actionable Insight
Expect sharp downside pressure as guidance cuts confirm deteriorating demand and execution. Monitor the May 6 earnings call for details on cost actions and B Medical sale timeline. The lack of buyback execution despite authorization suggests management priorities elsewhere.
Key Facts
- Q2 FY2026 revenue: $145M, up 1% YoY reported, organic down 3%
- GAAP diluted EPS from continuing ops: ($3.41) vs ($0.43) YoY, including $149M goodwill impairment
- Non-GAAP diluted EPS: ($0.04) vs $0.01 YoY
- FY2026 organic revenue guidance lowered to -2% to +1% from prior 3-5% growth
- FY2026 Adjusted EBITDA margin outlook cut to -125bps to flat from prior +300bps expansion
- Long-range plan extended from 2028 to 2029
- B Medical Systems sale delayed; buyer has not secured financing
- No share repurchases executed under $250M program
Financial Impact
Goodwill impairment of $149M; guidance revision implies $30-40M revenue reduction vs prior outlook
Risk Factors
- Further demand weakening in life sciences tools market
- B Medical Systems sale falling through, requiring additional cash outflows or write-downs
- Additional impairment charges if revenue trends continue declining
- Dilution from potential equity offering if cash needs arise
Market Snapshot
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-030677 |
| Document: azta-20260505.htm | 0001628280-26-030677 |
| Document: 0001628280-26-030677-index-headers.html | 0001628280-26-030677 |
| Document: 0001628280-26-030677-index.html | 0001628280-26-030677 |
| Document: 0001628280-26-030677.txt | 0001628280-26-030677 |
| 8-K Data (Synthetic) | 0001628280-26-030677 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 5, 2026
15d ago
|
8-K
| $18.38 $17.53 | ▲ +4.62% | ▲ +5.76% | $18.57 (−1.03%) |
|
Apr 7, 2026
6w ago
|
8-K
| $21.71 $24.26 | ▲ +11.75% | ▲ +6.42% | $18.57 (−14.46%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access